JP2015513544A5 - - Google Patents

Download PDF

Info

Publication number
JP2015513544A5
JP2015513544A5 JP2014559183A JP2014559183A JP2015513544A5 JP 2015513544 A5 JP2015513544 A5 JP 2015513544A5 JP 2014559183 A JP2014559183 A JP 2014559183A JP 2014559183 A JP2014559183 A JP 2014559183A JP 2015513544 A5 JP2015513544 A5 JP 2015513544A5
Authority
JP
Japan
Prior art keywords
chem
glp
compound according
peptide
amide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2014559183A
Other languages
English (en)
Japanese (ja)
Other versions
JP6300735B2 (ja
JP2015513544A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2013/053796 external-priority patent/WO2013127779A1/en
Publication of JP2015513544A publication Critical patent/JP2015513544A/ja
Publication of JP2015513544A5 publication Critical patent/JP2015513544A5/ja
Application granted granted Critical
Publication of JP6300735B2 publication Critical patent/JP6300735B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2014559183A 2012-03-01 2013-02-26 Glp−1プロドラッグ Active JP6300735B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP12157638 2012-03-01
EP12157638.3 2012-03-01
PCT/EP2013/053796 WO2013127779A1 (en) 2012-03-01 2013-02-26 Glp-1 prodrugs

Publications (3)

Publication Number Publication Date
JP2015513544A JP2015513544A (ja) 2015-05-14
JP2015513544A5 true JP2015513544A5 (enExample) 2016-03-03
JP6300735B2 JP6300735B2 (ja) 2018-03-28

Family

ID=47748659

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2014559183A Active JP6300735B2 (ja) 2012-03-01 2013-02-26 Glp−1プロドラッグ

Country Status (6)

Country Link
US (1) US9452225B2 (enExample)
EP (1) EP2820038B1 (enExample)
JP (1) JP6300735B2 (enExample)
CN (1) CN104185639B (enExample)
ES (1) ES2810153T3 (enExample)
WO (1) WO2013127779A1 (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4442314A2 (en) * 2015-10-28 2024-10-09 Tufts University Novel polypeptides with improved proteolytic stability, and methods of preparing and using same
HUE066356T2 (hu) 2017-08-24 2024-07-28 Novo Nordisk As GLP-1 készítmények és alkalmazásaik
CN109942696A (zh) * 2017-12-21 2019-06-28 中国药科大学 长效化胰高血糖素样肽-1(glp-1)类似物及其应用
IL281938B2 (en) 2018-10-26 2024-04-01 Novo Nordisk As Stable semaglutide compositions and uses thereof
PE20221575A1 (es) 2020-02-18 2022-10-06 Novo Nordisk As Formulaciones farmaceuticas
CN113336840B (zh) * 2020-03-02 2022-09-23 武汉帕肽生物医药有限责任公司 订书肽、其制备方法和用途
US20210318292A1 (en) * 2020-04-13 2021-10-14 Sensorium Bio, Inc. System and Method to Detect Small Molecules
EP4240420A1 (en) 2020-11-06 2023-09-13 Novo Nordisk A/S Glp-1 prodrugs and uses hereof
CN119173275A (zh) 2022-05-10 2024-12-20 诺和诺德股份有限公司 Glp-1多肽的前药及其用途
WO2025092778A1 (zh) * 2023-10-31 2025-05-08 深圳信立泰药业股份有限公司 Glp-1化合物及其制备方法与应用

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61143400A (ja) * 1984-12-17 1986-07-01 Kenji Okawa アクチノマイシンd様ペプチド
US4966848A (en) * 1988-02-08 1990-10-30 The General Hospital Corporation Isolation, purification, characterization, cloning and sequencing of N α-acetyltransferase
US5223421A (en) * 1989-10-25 1993-06-29 The General Hospital Corporation Identification of methionine Nα-acetyltransferase
US5688489A (en) * 1995-09-15 1997-11-18 Resolution Pharmaceuticals, Inc. Non-receptor mediated imaging agents
FR2777283B1 (fr) * 1998-04-10 2000-11-24 Adir Nouveaux composes peptidiques analogues du glucagon-peptide- 1 (7-37), leur procede de preparation et les compositions pharmaceutiques qui les contiennent
CA2462543A1 (en) * 2001-10-01 2003-04-10 Eli Lilly And Company Glucagon-like peptides (glp-1) and treatment of respiratory distress
ES2438145T3 (es) 2005-02-02 2014-01-16 Novo Nordisk A/S Nuevos derivados de insulina
US20110144010A1 (en) 2007-06-01 2011-06-16 Novo Nordisk A/S Spontaneously Dispersible Preconcentrates Including a Peptide Drug in a Solid or Semisolid Carrier
ES2672770T3 (es) 2007-09-05 2018-06-18 Novo Nordisk A/S Derivados del péptido-1 similar al glucagón y su uso farmacéutico
CN101220088B (zh) * 2007-09-24 2012-01-25 中国人民解放军第四军医大学 人胰高血糖素样肽-1类似物的融合蛋白及其应用
CA2707861A1 (en) 2007-10-30 2009-05-07 Indiana University Research And Technology Corporation Glucagon antagonists
JP5771005B2 (ja) 2007-10-30 2015-08-26 インディアナ ユニバーシティー リサーチ アンド テクノロジー コーポレーションIndiana University Research And Technology Corporation グルカゴンアンタゴニスト及びglp−1アゴニスト活性を示す化合物
US20100317057A1 (en) * 2007-12-28 2010-12-16 Novo Nordisk A/S Semi-recombinant preparation of glp-1 analogues
WO2009099763A1 (en) * 2008-01-30 2009-08-13 Indiana University Research And Technology Corporation Ester-based peptide prodrugs
KR20110114568A (ko) 2008-12-19 2011-10-19 인디애나 유니버시티 리서치 앤드 테크놀로지 코퍼레이션 디펩티드 링크된 약효 물질
RU2550696C2 (ru) 2008-12-19 2015-05-10 Индиана Юниверсити Рисерч Энд Текнолоджи Корпорейшн Основанные на амидах пролекарства пептидов глюкагонового надсемейства
CA2784757A1 (en) * 2009-12-16 2011-07-07 Novo Nordisk A/S Double-acylated glp-1 derivatives
MX2012014576A (es) * 2010-06-24 2013-02-21 Univ Indiana Res & Tech Corp Profarmacos de peptido de la superfamilia de glucagon basado en amida.

Similar Documents

Publication Publication Date Title
RU2012128547A (ru) Дважды ацилированные производные glp-1
JP2013530974A5 (enExample)
JP2011526886A5 (enExample)
JP2017500289A5 (enExample)
JP2013507439A5 (enExample)
WO2013002580A3 (ko) 폴리에틸렌글라이콜 또는 이의 유도체로 페길화된 엑센딘-4 유사체, 이의 제조방법 및 이를 유효성분으로 함유하는 당뇨병 예방 또는 치료용 약학적 조성물
JP2018506507A5 (enExample)
JP2013533227A5 (enExample)
JP2009501732A5 (enExample)
RU2015147876A (ru) Пероральная дозированная форма соединений глюкагоноподобного пептида-1
JP2014503526A5 (enExample)
TN2012000215A1 (en) Pharmaceutical compositions comprising a g l p -1 agonist and methionine
JP2018522843A5 (enExample)
RU2016135543A (ru) Новые производные инсулина и их применение в медицине
JP2013542247A5 (enExample)
MX355361B (es) Derivados de peptido 1 tipo glucagon (glp-1) doblemente acilados.
MY174002A (en) Combination theraphy for the treatment of diabetes
WO2009076173A3 (en) Fluorinated tripeptide hcv serine protease inhibitors
ME02666B (me) Cefalosporin sa kateholskom grupom
RU2020109881A (ru) Агонисты рецепторов glp-1/глюкагона в лечении жировой болезни печени и стеатогепатита
JP2013520405A5 (enExample)
JP2016519106A5 (enExample)
JP2016532716A5 (enExample)
RU2012150108A (ru) Аналоги глюкагоноподобного пептида-1 и их применение
JP2010523476A5 (enExample)